SKB264 Plus Glecirasib in Advanced KRAS G12C-Mutant NSCLC: A Phase II Study
Clinical trial NCT07670013 · RECRUITING
Trial details
- NCT number
- NCT07670013
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-01-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.